Dwaine Vance, Randox, on Molecular Diagnostics
At ECCMID, we caught up with Dwaine Vance from Randox, who discusses his company’s contribution to the field of diagnostics and healthcare. Randox is a leading provider of innovative diagnostic solutions for various medical applications.
Vance begins by highlighting Randox’s commitment to improving patient outcomes through advanced diagnostic technologies. He mentions the company’s extensive range of diagnostic products, including tests for infectious diseases.
He goes on to discuss Randox’s dedication to research and development, emphasizing the company’s investment in cutting-edge technologies and collaborations with renowned institutions. Vance explains that Randox’s focus is on developing accurate and reliable diagnostic tests that can aid in early disease detection, personalized treatment, and improved patient care.
- New “AI Doctor” Predicts Hospital Readmission and Other Health Outcomes Read more
- Axol Bioscience Collaborates with StrataStem to Deliver Stem Cell-Based ‘Clinical Trial in a Dish’ for Alzheimer’s Disease Read more
- MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator Read more
- XNK Therapeutics Appoints Hugo Petit as Chief Financial Officer Read more
- Bayer Strengthens Gene Therapy Portfolio With Lipid Nanoparticle Technology From Acuitas Therapeutics Read more